scholarly journals A Randomized Trial Comparing Intensive and Passive Education in Patients With Diabetes Mellitus

2002 ◽  
Vol 162 (11) ◽  
pp. 1301 ◽  
Author(s):  
Annaswamy Raji ◽  
Helen Gomes ◽  
Judith O. Beard ◽  
Patricia MacDonald ◽  
Paul R. Conlin
Keyword(s):  
Diabetes Mellitus ◽  
Randomized Trial ◽  
Patients With Diabetes ◽  
Passive Education

scholarly journals The Effects of Glucose Load on Catabolism during Remifentanil-Based Anesthesia in Patients with Diabetes Mellitus: A Prospective Randomized Trial

2015 ◽  
Vol 05 (07) ◽  
pp. 155-162 ◽  
Author(s):  
Maiko Hasegawa-Moriyama ◽  
Mayumi Nakahara ◽  
Takayuki Saito ◽  
Tomotsugu Yamada ◽  
Keika Mukaihara ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Randomized Trial ◽  
Prospective Randomized Trial ◽  
Glucose Load ◽  
Patients With Diabetes

scholarly journals ATRIAL FIBRILLATION COMBINED WITH DIABETES MELLITUS. POSSIBILITIES OF USING RIVAROXABAN

2018 ◽  
pp. 68-74
Author(s):  
Alexey D. Ehrlich
Keyword(s):  
Diabetes Mellitus ◽  
Atrial Fibrillation ◽  
Randomized Trial ◽  
Oral Anticoagulant ◽  
Observational Studies ◽  
Theoretical Data ◽  
Comparative Efficacy ◽  
Systemic Embolism ◽  
Actual Clinical Practice ◽  
Patients With Diabetes

The presented material summarizes the main clinical and theoretical data on the peculiarities of atrial fibrillation (AP) flow in combination with diabetes mellitus (DM). This combination, although associated with a lower age than in patients without diabetes, is associated with a higher risk of stroke and systemic embolism and other adverse complications. The material presents the data of the rocket-AF randomized trial subanalysis on the peculiarities of the use of oral anticoagulant - a direct inhibitor of Xa-factor Rivaroxaban in patients with non-valve AF in combination with DM. Comparative efficacy and safety of Rivaroxaban in patients with diabetes were comparable to those in patients without diabetes. Rivaroxaban in patients with diabetes was associated with lower vascular death rates than warfarin. The results of the randomized trial are largely confirmed in several observational studies that reflect actual clinical practice. Thus, it can be affirmed that Rivaroxaban is not only the most commonly used direct oral anticoagulant in russian practice, but can also be widely used in patients with non-valve AF and diabetes to prevent strokes and systemic embolisms.

Intramuscular Nerve and Neuromuscular Junction Alteration In Extraocular Muscles of Diabetic Mice

1985 ◽  
Vol 43 ◽  
pp. 682-683
Author(s):  
Bruce R. Pachter
Keyword(s):  
Diabetes Mellitus ◽  
Peripheral Nerves ◽  
Sudden Onset ◽  
Extraocular Muscles ◽  
Diabetic Patients ◽  
Oculomotor Palsy ◽  
Third Nerve Palsy ◽  
Patients With Diabetes ◽  
Intramuscular Nerve ◽  
Oculomotor Nerves

Diabetes mellitus is one of the commonest causes of neuropathy. Diabetic neuropathy is a heterogeneous group of neuropathic disorders to which patients with diabetes mellitus are susceptible; more than one kind of neuropathy can frequently occur in the same individual. Abnormalities are also known to occur in nearly every anatomic subdivision of the eye in diabetic patients. Oculomotor palsy appears to be common in diabetes mellitus for their occurrence in isolation to suggest diabetes. Nerves to the external ocular muscles are most commonly affected, particularly the oculomotor or third cranial nerve. The third nerve palsy of diabetes is characteristic, being of sudden onset, accompanied by orbital and retro-orbital pain, often associated with complete involvement of the external ocular muscles innervated by the nerve. While the human and experimental animal literature is replete with studies on the peripheral nerves in diabetes mellitus, there is but a paucity of reported studies dealing with the oculomotor nerves and their associated extraocular muscles (EOMs).

Sign in / Sign up

Export Citation Format

Share Document